{"id":"W4404367648","doi":"10.1016/j.ctrv.2024.102853","title":"Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer","year":2024,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"Seagen; Pfizer","keywords":"Medicine; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Breast cancer; Oncology; Cancer; Internal medicine; Epidermal growth factor receptor; Lapatinib; Cancer research; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007927395,0.001692715,0.006446705,0.0007107217,0.0002724007,0.0001347516,0.0002484623,0.0004073237,0.001972999],"category_scores_gemma":[0.00008011144,0.001043947,0.00156939,0.0007894149,0.0002322651,0.0001641447,0.0001204679,0.001124091,0.0002648561],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02607979,"about_ca_system_score_gemma":0.002796564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006522052,"about_ca_topic_score_gemma":0.001404589,"domain_scores_codex":[0.9919002,0.001901158,0.00257158,0.002093254,0.0004833612,0.001050447],"domain_scores_gemma":[0.9968293,0.0007328927,0.0006965846,0.0008797464,0.0001498294,0.0007115992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005259789,0.0006411179,0.0001892577,0.01001146,0.002105082,0.0003112518,0.001311632,7.654523e-7,0.000003720363,0.00003475367,0.002607458,0.9827309],"study_design_scores_gemma":[0.001730215,0.00178504,0.0001146675,0.1349383,0.004419856,0.0001554355,0.0001253621,0.00002152608,0.00002120695,0.000005450549,0.8559099,0.0007730319],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001297707,0.9836787,0.000007072461,0.003323528,0.0007722771,0.009197165,0.002233796,0.00009361215,0.0005640515],"genre_scores_gemma":[0.0001352525,0.9806316,0.0003113353,0.0004142746,0.001227269,0.01433977,0.0008914865,0.0002699679,0.001778987],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9819579,"threshold_uncertainty_score":0.9995819,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3394679420235394,"score_gpt":0.5386860887968553,"score_spread":0.1992181467733159,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}